Oxygenta Pharmaceutical has informed that it enclosed Certificate issued under Reg. 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by Vanitha Nagulavari, Practicing Company Secretary for the year ended 31-03-2023.
The above information is a part of company’s filings submitted to BSE.